Deep Brain Stimulator Market - Global Industry Analysis, Size, Share, Growth, Trends, And Forecast To 2025

Deep brain stimulation is a technique that comprises implanting electrodes within specified areas of a patient’s brain. Such electrodes are also known as “brain electrodes” and they emit electrical impulses that regulate abnormal impulses caused by various neurological diseases. The amount of stimulation in this technique is controlled by a device resembling pacemaker that is set beneath the skin on the upper chest of the patient. A connecting wire travels beneath the patient’s skin to the electrodes in the patient’s brain.

Deep brain stimulation (DBS) device is essentially utilized to alleviate symptoms of Parkinson’s disease (PD) as once implanted at one of the three FDA approved brain sites, these electrodes block the electrical signals from these sites to the brain. Namely, Ventrointermedialis (VIM) nucleus of the thalamus, subthalamic nucleus (STN) and globus pallidus pars interna (GPi) are the three FDA approved targeted brain sites for combating Parkinson’s.

One of the most essential factors fuelling DBS market is the increasing cases of Parkinson’s disease. Although there are various surgical options available i.e such as thalamotomy, pallidotomy etc, deep brain stimulation stands as the most widely preferred surgical option owing to the absence of tissue destruction and reversible nature of the surgical treatment. Thus, owing to the fewer complications of this surgical treatment, this market is estimated to grow substantially over the forecast period. Medtronic’s device Activa PC+S system is a closed-loop DBS device capable of developing an algorithm of the closed-loop system while simultaneously recording the electrical activities in brain. This device is anticipated to be tested positive for a permanent treatment of advanced Parkinson disease. Advent of such devices in the market is projected to benefit patients suffering with Parkinsons, thereby augmenting the deep brain stimulation devices market.

Request For Free Sample Of The Report @ https://www.xpodenceresearch.com/Request-Sample/106924

Long term medication which is relatively steep in nature makes treatment of Parkinson and Alzheimer disease extremely unaffordable to a huge section of the population in emerging economies. DBS, on the other hand is a minimally-invasive technology with a long term solution for such chronic ailments. This factor has led to the increased demand for such procedures and devices to aid in the treatment of chronic disease conditions such as blood clot, diabetes, Parkinson’s disease, Alzheimer’s disease and stroke thereby augmenting the deep brain stimulation devices market.

Various novel applications of deep brain stimulation devices particularly for Alzheimer and tinnitus treatment are expected to create new opportunities in the market. Additionally, medical professionals increasingly prefer deep brain stimulation techniques over drug therapy in order to avoid numerous side effects, thereby boosting the demand for global deep brain stimulation devices. However, high cost of devices and increased risk of infection due to implantation of foreign object in the body, battery failure and allergic reaction may constraint the growth of deep brain stimulation device market.

The global deep brain stimulation devices market is segmented into DBS type Application and Geography. On the basis of DBS types, the market is segregated into Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS and Pedunculopontine nucleus DBS. Based on application, the market is bifurcated into pain management, epilepsy, obsessive compulsive disorder (OCD), depression, parkinson disease, essential tremor and dystonia. Geographically, the market is segmented into four regions namely North America, Europe, Asia Pacific, Middle East and Africa and .Latin America.

Obtain Report Details @ https://www.xpodenceresearch.com/Reports/Deep-Brain-Stimulator-Market

Some of the major market players have adopted the strategy of acquisition for enhancing the DBS market. For instance, Neurotech has been acquired by Sorin group in order to increase its product portfolio in the DBS market. The companies profiled in this report are Medtronic, Boston Scientific Corporation, Enteromedics, Cyberonics, St. Jude Medical, Neuropace, Zynex, Neuronetics, Functional Neuromodulation, Microtransponder and Neurosigma.

About Us-

Xpodence Research is a U.S. based Market Research Company and offers the most extensive collection of progressive surveying syndicated and customized research reports of various categories for private and public industries across the globe.

We offer the comprehensive market research solution for all the industries by performing the in-depth study of industry trends, verticals globally. We believe in building an eternal bond with our customers through providing them inclusive research study both customized and syndicated based on their specific requirements.

The organizations in every industry such as Technology, Pharmaceuticals, Consumable Goods, Food & Beverage and others demands a market-based solutions for various significant decisions based on productivity and output globally. Our services are tailored specifically to our clients by proposing them the potential outcome, based on our in-depth analysis and insights for exploring the growth strategies through providing the best possible decision for quality production.

Contact Us-

Xpodence Research
USA Office
244 , Madison Avenue
New York City, NY - 10016
United States
Toll Free +1- 844-445-2861
Email-sales@xpodenceresearch.com

This release was published on openPR.